AktoCyte Tablets: Transforming Cancer Care for Pelvic Cancer Patients

Context: Scientists from the Department of Atomic Energy and M/s. IDRS Labs Bengaluru have joined hands to develop Aktocyte tablets for treating pelvic cancer.

AktoCyte Tablets Gain FSSAI Approval: Market Launch Set for January 2024

Approval: The AKTOCYTE tablet has received approval from the Food Safety and Standards Authority of India (FSSAI)

• Market Availability: These tablets will be available for purchase from January 2024.

AKTOCYTE Tablets Revolutionize Pelvic Cancer Care

• Uses: The AKTOCYTE tablets have been effective, particularly in pelvic cancer patients suffering from radiotherapy-induced Cystitis (Blood in urine).
  • Further, these tablets have been designed as a nutraceutical, an adjuvant to cancer radiotherapy and antioxidant. 
• Performance: Patients treated with Aktocyte tablets demonstrated an extraordinary recovery, eliminating the need for surgical removal of the urinary bladder.

Nutraceuticals: Bridging Nutrition and Medicine for Health

• The term “nutraceutical” was coined in 1989 by Stephen DeFelice.
• Definition: Nutraceutical products are products derived from food sources that provide both nutritional and medicinal benefits. 
• Meaning: The term “nutraceutical” combines the two words  “nutrient,” which is a nourishing food component, and “pharmaceutical,” which is a medical drug
• Mechanism: They contain a high concentration of bioactive compounds, derived from a natural source and have physiological benefits and aid in the prevention and treatment of disease.
• Types: Nutraceuticals can be grouped into four categories that are dietary supplements, functional food, medicinal food, and farmaceuticals.
• Examples: Probiotics: Beneficial bacteria that support gut health and digestion.; Green tea extract: Rich in antioxidants and associated with various health benefits.

Source: PIB

DOWNLOAD PDF